Skip to main content

Table 1 Characteristic of bladder urothelial carcinoma patients

From: Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma

Covariates

Type

Total

Test

Train

Pvalue

Age

≤ 65

159(39.45%)

78(38.81%)

81(40.1%)

0.870

 

> 65

244(60.55%)

123(61.19%)

121(59.9%)

Gender

FEMALE

106(26.3%)

51(25.37%)

55(27.23%)

0.757

 

MALE

297(73.7%)

150(74.63%)

147(72.77%)

Grade

High Grade

380(94.29%)

189(94.03%)

191(94.55%)

1.000

 

Low Grade

20(4.96%)

10(4.98%)

10(4.95%)

 
 

unknow

3(0.74%)

2(1%)

1(0.5%)

 

Stage

Stage I

2(0.5%)

1(0.5%)

1(0.5%)

0.867

 

Stage II

127(31.51%)

63(31.34%)

64(31.68%)

 

Stage III

140(34.74%)

73(36.32%)

67(33.17%)

 

Stage IV

132(32.75%)

62(30.85%)

70(34.65%)

 

unknow

2(0.5%)

2(1%)

0(0%)

 

T

T1

3(0.74%)

2(1%)

1(0.5%)

0.927

 

T2

117(29.03%)

60(29.85%)

57(28.22%)

 

T3

193(47.89%)

95(47.26%)

98(48.51%)

 

T4

57(14.14%)

29(14.43%)

28(13.86%)

 

unknow

33(8.19%)

15(7.46%)

18(8.91%)

 

M

M0

194(48.14%)

100(49.75%)

94(46.53%)

1.000

 

M1

11(2.73%)

6(2.99%)

5(2.48%)

 
 

unknow

198(49.13%)

95(47.26%)

103(50.99%)

N

N0

234(58.06%)

123(61.19%)

111(54.95%)

0.239

 

N1

46(11.41%)

25(12.44%)

21(10.4%)

 
 

N2

75(18.61%)

34(16.92%)

41(20.3%)

 
 

N3

6(1.49%)

1(0.5%)

5(2.48%)

 
 

unknow

42(10.42%)

18(8.96%)

24(11.88%)